Top news of the week: 05.08.2022.
Biotech’s Prospects Transition from Hero to Zero and – Maybe – Back Again
The biotech industry is facing what some consider the worst times since its inception. Several market analysts recently shared their thoughts.
Pfizer terminates PhIII study of rare cardiovascular drug picked up in $11.4B Array acquisition
While Pfizer's $11.4 billion acquisition of Array BioPharma in the summer of 2019 was mainly focused on oncology, namely Braftovi and Mektovi, there were a few non-cancer assets, including ...
The BWB Awards at Biotech Week Boston 2022: Celebrating excellence in life sciences
Join us fora night of dinner, drinks, and entertainment on Tuesday 27 September 2022 as we honor innovation and expertise in the biopharma world.Entries now being accepted until August 5th ...
Helping Biopharma Overcome the Challenges to Go Digital
Despite much interest, digitizing manufacturing is still far from straightforward for biopharmaceutical firms used to more traditional production methods.
Theranos’ Epic Self-Destruction Offers Lessons for Biotech Companies
Whistleblowers Erika Cheung and Tyler Shultz discussed their experiences at Theranos during the recent 2022 AACC Annual Scientific Meeting & Clinical Lab Expo.
Thermo Fisher Scientific and Structura Biotechnology Collaborate to Offer a Solution for Real-Time Cryo-EM Data Analysis
New Embedded CryoSPARC Live software to be made available by Structura and Thermo Fisher and designed to integrate with Thermo Fisher technologyHILLSBORO, Ore.--(BUSINESS WIRE)--Thermo ...
July Brings Layoffs, Job Creation for the Life Sciences
July continued the trend of life sciences layoffs that we’ve seen so far this year. In contrast, several companies have created jobs through expansions. For that and more, continue reading.